Clinical Trials · NCT00042471
Evaluation of the Bioavailability of Pramlintide
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 75
- Start date
- Jun 2002
- Locations
- 4 sites, United States
- Primary endpoint
- Effect of varying needle length on bioavailability of Pramlintide